Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Catholic University Leuven
Leuven, Belgium
- London Health Sciences Centre
London, Ontario, Canada
- Centre Hospitalier Regional Universitaire (chru) Montpellier - Hopital Gui de Chauliac
Montpellier, France
- Groupe Hospitalier Pitie-Salpetriere - Centre D'Investigation Clinique Neurosciences 1422
Paris, France
- Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (cvk) - Ambulanz Fuer Als Und Andere Motoneuronenerkrankungen
Berlin, Germany
- Medizinische Hochschule Hannover (mhh) - Klinik Fuer Neurologie
Hanover, Germany
- Universitaetsklinikum Ulm - Klinik Fuer Neurologie
Ulm, Germany
- Instituti Clinica Scientifici Maugeri
Milan, Italy
- Azienda Ospedaliero Universitaria (auo) Di Torino - Citta'Della Salute E Della Scienza Di Torino
Torino, Italy
- University Medical Center Utrecht
Utrecht, Netherlands
- Centrum Medyczne Neuroprotect
Warsaw, Poland
- Citi Clinic
Warsaw, Poland
- Hospital Universitario Vall D'Hebron Als Unit. Consultas Externas; Office: 9-10-11
Barcelona, Spain
- Hospital Carlos Iii - Hospital Universitario la Paz, Als Unit
Madrid, Spain
- Umeå University Hospital
Umeå, Sweden
- Leonard Wolfson Experimental Neurology Centre
London, United Kingdom
- St. Joseph'S Hospital and Medical Center (sjhmc) - Barrow Neurological Institute (bni) - the Gregory W. Fulton Als and Neuromuscular Disease Center
Phoenix, Arizona, United States
- Uc Irvine Health Als and Neuromuscular Center
Orange, California, United States
- University of Miami
Miami, Florida, United States
- Hospital for Special Surgery
New York, New York, United States
- Providence Brain & Spine Institute
Portland, Oregon, United States
- University of Pensylvania, Perelman Center for Advanced Medicine - Penn Neuroscience Center
Philadelphia, Pennsylvania, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Sept 2019
- Primary completion
- 2 Jul 2021
- Completion
- 2 Jul 2021
- Last update posted
- 24 Aug 2023
- Registered enrollment
- 120
- Registry id
- NCT03836716
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.